0      0

Lumasiran for Patients with Primary Hyperoxaluria Type 1 and Impaired Kidney Function: 12-Month Analysis of the Phase 3 ILLUMINATE-C Trial



Credits: None available.


Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.